CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

323U66 (Bupropion Hydrochloride Sustained Release) - Phase 3 | GSK Pipeline | CatalystAlert